← Back to Search

Genetic Screening for Cancer

N/A
Waitlist Available
Led By Kenneth Offit, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with a histologic diagnosis of cancer of the colon, breast, bladder, kidney, testicles, lungs, prostate, head and neck, or lymphoid organs, who have donated a diagnostic blood sample as either an inpatient or outpatient at MSKCC.
All patients who have two or more histologic diagnoses of the same primary tumor type involving the above sites.
Must not have
MSKCC patients without a histologic diagnosis of cancer of the breast, bladder, kidney, colon, testicles, lungs, prostate, or lymphoid malignancy (including all types of lymphoma) will not be eligible for the AMDeC sponsored component of the study.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial is looking at whether there is any link between cancer and genes. It is designed to help create ideas for future research.

Who is the study for?
This trial is for Ashkenazi Jewish individuals with a confirmed cancer diagnosis, including kidney, breast, colon, prostate, lung, ovarian, bladder cancers or lymphoid malignancies. Eligible participants must have donated a blood sample at MSKCC and can have multiple diagnoses of the same cancer type.
What is being tested?
The study is exploring if there's a link between inherited genetic variations (germline polymorphisms) and various cancers using PCR/PCR/LDR strategy to analyze DNA. It aims to generate hypotheses for future research rather than test a treatment.
What are the potential side effects?
Since this trial involves genetic testing without direct medical interventions like drugs or surgery, it does not typically present side effects in the traditional sense as seen with medication or surgical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have cancer in one of the specified organs and have given a blood sample at MSKCC.
Select...
I have had the same type of cancer diagnosed in two or more separate instances.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have a confirmed diagnosis of cancer in specific organs or lymphoma for the AMDeC study part.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: 1Active Control1 Intervention
All incident second primary cancers of colon, breast, bladder, kidney, prostate, ovarian cancer lung cancer and lymphoid cancer diagnosed between 1999 and present will be included in the secondary design to compare second primary cancer "cases" and first primary "controls".
Group II: 2Placebo Group1 Intervention
Controls will be volunteer blood donors from the New York Blood Center as well as normal volunteers from other AMDeC sites.

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,956 Previous Clinical Trials
574,475 Total Patients Enrolled
Weill Medical College of Cornell UniversityOTHER
1,077 Previous Clinical Trials
1,299,586 Total Patients Enrolled
Columbia UniversityOTHER
1,471 Previous Clinical Trials
2,515,269 Total Patients Enrolled

Media Library

1 Clinical Trial Eligibility Overview. Trial Name: NCT00579514 — N/A
Lung Cancer Research Study Groups: 2, 1
Lung Cancer Clinical Trial 2023: 1 Highlights & Side Effects. Trial Name: NCT00579514 — N/A
1 2023 Treatment Timeline for Medical Study. Trial Name: NCT00579514 — N/A
~351 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top